Bath & Body Works (NYSE:BBWI – Get Free Report) issued an update on its fourth quarter 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 1.410-1.610 for the period, compared to the consensus estimate of 1.720. The company issued revenue guidance of $2.6 billion-$2.7 billion, compared to the consensus revenue estimate of $2.7 billion. Bath & Body Works also updated its FY 2026 guidance to 2.600-2.800 EPS.
Analyst Ratings Changes
Several research firms have recently weighed in on BBWI. Weiss Ratings reissued a “hold (c-)” rating on shares of Bath & Body Works in a research note on Tuesday, October 6th. Argus reiterated a “hold” rating on shares of Bath & Body Works in a research note on Wednesday, September 16th. Barclays cut their price target on Bath & Body Works from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Thursday, August 27th. UBS Group decreased their price objective on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a report on Friday. Finally, Morgan Stanley decreased their target price on Bath & Body Works from $22.00 to $21.00 and set an “equal weight” rating for the company in a research note on Friday. Four equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Bath & Body Works currently has an average rating of “Hold” and an average target price of $22.00.
Check Out Our Latest Stock Report on Bath & Body Works
Bath & Body Works Stock Down 1.3%
Shares of BBWI stock opened at $18.67 on Friday. The company has a market capitalization of $3.76 billion, a P/E ratio of 5.10, a P/E/G ratio of 0.97 and a beta of 1.31. Bath & Body Works has a 12-month low of $14.27 and a 12-month high of $24.94. The firm has a 50-day moving average price of $19.24 and a 200 day moving average price of $19.75.
Bath & Body Works (NYSE:BBWI – Get Free Report) last released its quarterly earnings results on Thursday, November 19th. The company reported $0.26 EPS for the quarter, topping analysts’ consensus estimates of $0.12 by $0.14. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%. Bath & Body Works’s revenue for the quarter was down 1.1% on a year-over-year basis. During the same period in the prior year, the company earned $0.37 EPS. Bath & Body Works has set its Q4 2026 guidance at 1.410-1.610 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, research analysts expect that Bath & Body Works will post 2.77 earnings per share for the current year.
Bath & Body Works Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, December 4th. Stockholders of record on Friday, November 20th will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 4.3%. The ex-dividend date of this dividend is Friday, November 20th. Bath & Body Works’s dividend payout ratio (DPR) is 20.83%.
Key Stories Impacting Bath & Body Works
Investors following BBWI have been watching these stories:
- Positive Sentiment: The company raised its full-year sales outlook and announced a new $500 million share-repurchase program. It maintained adjusted FY2026 EPS guidance of $2.60–$2.80. Bath & Body Works Q3 results and outlook
- Neutral Sentiment: A limited-edition holiday fragrance collection with Pantone adds a product and gifting initiative, though its near-term financial impact is unclear. Bath & Body Works and Pantone holiday collection
- Negative Sentiment: Q4 EPS guidance of $1.41–$1.61 came in below the $1.72 analyst consensus, with revenue guidance also below expectations at the midpoint. Reports of softer expected holiday sales add to concerns about near-term demand. Bath & Body Works trims FY26 EPS outlook
About Bath & Body Works
Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.
Featured Stories
- Five stocks we like better than Bath & Body Works
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
